Fresenius SE & Co. KGaA

XTRA:FRE Stock Report

Market Cap: €18.7b

Fresenius SE KGaA Past Earnings Performance

Past criteria checks 0/6

Fresenius SE KGaA's earnings have been declining at an average annual rate of -25.1%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 13.1% per year.

Key information

-25.1%

Earnings growth rate

-25.3%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate-13.1%
Return on equity1.8%
Net Margin-2.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Dec 20
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Getting In Cheap On Fresenius SE & Co. KGaA (ETR:FRE) Might Be Difficult

Nov 29
Getting In Cheap On Fresenius SE & Co. KGaA (ETR:FRE) Might Be Difficult

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jul 15
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Jun 12
Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

May 28
At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

May 02
With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Mar 29
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Mar 13
Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

Feb 06
Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Jan 19
A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Jan 03
Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Revenue & Expenses Breakdown

How Fresenius SE KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

XTRA:FRE Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2422,811-4793,178615
30 Jun 2422,6327213,203615
31 Mar 2422,4174203,173604
31 Dec 2322,2993533,155608
30 Sep 2321,3611,8103,183647
30 Jun 2321,5605553,238625
31 Mar 2317,0719522,365578
31 Dec 2221,5321,1543,094614
30 Sep 2225,8281,4443,561610
30 Jun 2229,7661,6114,080677
31 Mar 2238,2561,7965,580777
31 Dec 2137,5201,8185,453784
30 Sep 2136,8581,7295,423800
30 Jun 2136,4521,7435,341757
31 Mar 2136,1261,6835,149758
31 Dec 2036,2771,7075,235758
30 Sep 2036,2841,8125,378741
30 Jun 2036,2081,8295,418752
31 Mar 2036,0491,8895,517698
31 Dec 1935,4091,8835,406660
30 Sep 1934,9331,8845,159644
30 Jun 1934,2831,8595,105613
31 Mar 1933,9042,0404,991635
31 Dec 1833,5302,0274,893646
30 Sep 1833,3902,0225,136660
30 Jun 1833,4951,9995,177640
31 Mar 1833,6451,7975,341596
31 Dec 1733,8861,8145,554558
30 Sep 1733,0111,7455,192524
30 Jun 1732,1471,7315,143513
31 Mar 1730,8181,6594,933508
31 Dec 1629,4711,5604,742502
30 Sep 1628,9081,4774,620480
30 Jun 1628,4151,4524,489473
31 Mar 1628,1581,3994,413473
31 Dec 1527,6261,3584,195464
30 Sep 1526,8891,2564,031443
30 Jun 1525,9271,1753,832422
31 Mar 1524,5021,1363,533394
31 Dec 1423,2311,0673,359369
30 Sep 1422,0101,0943,170359
30 Jun 1421,0771,0833,057351
31 Mar 1420,6531,0403,055352
31 Dec 1320,3311,0113,044348

Quality Earnings: FRE is currently unprofitable.

Growing Profit Margin: FRE is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: FRE is unprofitable, and losses have increased over the past 5 years at a rate of 25.1% per year.

Accelerating Growth: Unable to compare FRE's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FRE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).

Return on Equity

High ROE: FRE has a negative Return on Equity (1.85%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:51
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fresenius SE & Co. KGaA is covered by 49 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Martin SchneeAlphaValue
Hassan Al-WakeelBarclays
Robert BateBarclays